Cytostatic modifiers: current status and considerations for the future.
Howell
S B
SB
Department of Medicine, University of California, San Diego, La Jolla 92093.
Goel
R
R
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000188:drug therapy; D004334:Drug Administration Schedule; D004357:Drug Synergism; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006801:Humans; D007263:Infusions, Parenteral / Q000379:methods; D012004:Rectal Neoplasms / Q000188:drug therapy